{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:58:25Z","timestamp":1785787105412,"version":"3.56.0"},"reference-count":65,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Epstein-Barr virus (EBV) seropositivity is associated with chronic immune dysregulation conditions, including multiple sclerosis, systemic lupus erythematosus, post\u2013COVID-19 condition, and multiple cancers. Sepsis is an acute immune dysregulation condition attributed to 1 of 5 global deaths.<\/jats:p><\/jats:sec>Objective<\/jats:title>To assess causal associations among EBV seropositivity, immune dysregulation, and mortality in children with sepsis.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cohort study analyzed 320 children with sepsis in the 9-center Eunice Kennedy Shriver National Institutes of Child Health and Development Collaborative Pediatric Critical Care Research Network Phenotyping Pediatric Sepsis-Induced Multiple Organ Failure (PHENOMS) study who had not previously received intravenous immune globulin. Blood samples and clinical data were collected from January 1, 2015, to December 31, 2018, and assayed from January 1, 2019, to December 31, 2022. Causal algorithms were modeled in directed acyclic graphs and subsequent sensitivity and mediation analyses applied with further confirmation by structural equation modeling. Data analysis was performed from May 2022 to January 2025.<\/jats:p><\/jats:sec>Intervention<\/jats:title>Blood sample collected at 24 to 48 hours of sepsis.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Circulating biomarkers of inflammation (C-reactive protein, ferritin, and 32 cytokines), immune depression (ex vivo tumor necrosis factor response to endotoxin\u2009&amp;lt; 200 pg\/mL), thrombotic microangiopathy (ADAMTS13 activity &amp;lt;57%), and EBV seropositivity (viral capsid IgG) were measured. Causal inference analysis identified causal associations between EBV seropositivity, immune dysregulation biomarkers, macrophage activation syndrome, and death.<\/jats:p><\/jats:sec>Results<\/jats:title>Of the 320 children (median [IQR] age, 6 [1-12] years; 172 [53.8%] male), 150 (46.9%) were previously healthy, and 72 (22.5%) had immunocompromise at admission. A total of 172 (53.8%) had causal associations with death directly and through the mediators hyperferritinemia and macrophage activation syndrome (MAS) and also had direct causal associations with increased C-reactive protein, ferritin, and interleukin 18 binding protein, which in turn had direct causal associations with decreased ADAMTS 13 activity and decreased whole blood ex vivo tumor necrosis factor response to endotoxin. Mediation analysis found that EBV seropositivity was associated with mortality (estimate [SE], 1.86 [0.55]; P<\/jats:italic>\u2009&amp;lt;\u2009.001). With both EBV seropositivity and ferritin included in the model, the effect of EBV seropositivity on death remained (estimate [SE], 1.52 [0.57]; P<\/jats:italic>\u2009=\u2009.007), as did the ferritin effect (estimate [SE], 0.50 [0.15]; P<\/jats:italic>\u2009=\u2009.001). EBV seropositivity remained significantly associated with death even after adjustment for MAS (estimate [SE], 1.78 [0.56]; P<\/jats:italic>\u2009=\u2009.001).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this cohort study of pediatric sepsis, EBV seropositivity was associated with immune dysregulation and mortality. Further study is warranted to address the possibility that latent EBV infection immune reprogramming poses an important public health problem that contributes to not only chronic disorders of immune dysregulation but also acute disorders of immune dysregulation, such as sepsis.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.27487","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:00:27Z","timestamp":1755615627000},"page":"e2527487","source":"Crossref","is-referenced-by-count":4,"title":["Epstein-Barr Virus Seropositivity, Immune Dysregulation, and Mortality in Pediatric Sepsis"],"prefix":"10.1001","volume":"8","author":[{"given":"Aditya","family":"Sriram","sequence":"first","affiliation":[{"name":"Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate F.","family":"Kernan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Critical Care Medicine, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidi","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Aldewereld","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Critical Care Medicine, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H.","family":"Walton","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Cabler","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Storch","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Cheynet","sequence":"additional","affiliation":[{"name":"bioMerieux, Marcy-l'\u00c9toile, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Brengel-Pesce","sequence":"additional","affiliation":[{"name":"bioMerieux, Marcy-l'\u00c9toile, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Canna","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Carcillo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Critical Care Medicine, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Berg","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy L.","family":"Meert","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Central Michigan University, Detroit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Pollack","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, George Washington University, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit","family":"Newth","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Harrison","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Shanley","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Remy","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Washington University in St Louis, St Louis, Missouri"},{"name":"Department of Pediatrics, Case Western Reserve University, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jung","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"issue":"5","key":"zoi250780r1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064921","article-title":"Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010.","volume":"8","author":"Dowd","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"zoi250780r2","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1186\/s12889-020-09049-x","article-title":"Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom.","volume":"20","author":"Kuri","year":"2020","journal-title":"BMC Public Health"},{"issue":"1","key":"zoi250780r3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13027-023-00534-7","article-title":"Epstein-Barr virus (EBV) antibody changes over time in a general population cohort in rural Uganda, 1992-2008.","volume":"18","author":"Sabourin","year":"2023","journal-title":"Infect Agent Cancer"},{"issue":"5","key":"zoi250780r4","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1651-2227.1985.tb10015.x","article-title":"Epstein-Barr virus infection and serological profile in Greenland Eskimo children.","volume":"74","author":"Albeck","year":"1985","journal-title":"Acta Paediatr Scand"},{"issue":"9","key":"zoi250780r5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1055\/s-0030-1253098","article-title":"Prevalence of Epstein-Barr virus reactivation in pregnancy.","volume":"27","author":"Haeri","year":"2010","journal-title":"Am J Perinatol"},{"issue":"3","key":"zoi250780r6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1212\/WNL.35.3.435","article-title":"Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis.","volume":"35","author":"Larsen","year":"1985","journal-title":"Neurology"},{"issue":"6578","key":"zoi250780r7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis.","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"issue":"1","key":"zoi250780r8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","article-title":"Epstein-Barr virus and multiple sclerosis.","volume":"21","author":"Soldan","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"zoi250780r9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2022-000271","article-title":"Serum IgG levels to Epstein-Barr and measles viruses in patients with multiple sclerosis during natalizumab and interferon beta treatment.","volume":"4","author":"Persson Berg","year":"2022","journal-title":"BMJ Neurol Open"},{"issue":"7","key":"zoi250780r10","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/jnnp-2020-322941","article-title":"Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis.","volume":"91","author":"Abrahamyan","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"zoi250780r11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/1352458519872664","article-title":"Environmental factors and risk of multiple sclerosis: Findings from meta-analyses and Mendelian randomization studies.","volume":"26","author":"Belbasis","year":"2020","journal-title":"Mult Scler"},{"issue":"11","key":"zoi250780r12","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1212\/01.wnl.0000247665.94088.8d","article-title":"High seroprevalence of Epstein-Barr virus in children with multiple sclerosis.","volume":"67","author":"Pohl","year":"2006","journal-title":"Neurology"},{"issue":"15","key":"zoi250780r13","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1001\/jama.291.15.1875","article-title":"Epstein-Barr virus in pediatric multiple sclerosis.","volume":"291","author":"Alotaibi","year":"2004","journal-title":"JAMA"},{"issue":"10","key":"zoi250780r14","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1136\/jnnp.2004.048504","article-title":"Epstein-Barr virus and disease activity in multiple sclerosis.","volume":"76","author":"Buljevac","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"zoi250780r15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/BF02943612","article-title":"Antibodies to Epstein-Barr viral antigens in familial rheumatoid arthritis.","volume":"158","author":"McDermott","year":"1989","journal-title":"Ir J Med Sci"},{"issue":"1","key":"zoi250780r16","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2017-000214","article-title":"Strong viral associations with SLE among Filipinos.","volume":"4","author":"Vista","year":"2017","journal-title":"Lupus Sci Med"},{"key":"zoi250780r17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.587380","article-title":"Epstein-Barr Virus and Systemic Autoimmune Diseases.","volume":"11","author":"Houen","year":"2021","journal-title":"Front Immunol"},{"issue":"8","key":"zoi250780r18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/BF02943612","article-title":"Antibodies to Epstein-Barr viral antigens in familial rheumatoid arthritis.","volume":"158","author":"McDermott","year":"1989","journal-title":"Ir J Med Sci"},{"issue":"9","key":"zoi250780r19","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1177\/08850666211053990","article-title":"Reactivation of EBV and CMV in severe COVID-19-epiphenomena or trigger of hyperinflammation in need of treatment? a large case series of critically ill patients.","volume":"37","author":"Naendrup","year":"2022","journal-title":"J Intensive Care Med"},{"issue":"11","key":"zoi250780r20","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1002\/jmv.27994","article-title":"SARS-CoV-2 infection and lytic reactivation of herpesviruses: a potential threat in the postpandemic era?","volume":"94","author":"Chen","year":"2022","journal-title":"J Med Virol"},{"issue":"1","key":"zoi250780r21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12885-023-10709-5","article-title":"Pre-diagnostic anti-EBV antibodies and primary liver cancer risk: a population-based nested case-control study in southern China.","volume":"23","author":"Du","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"zoi250780r22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0215(19990702)82:1<1::AID-IJC1>3.0.CO;2-L","article-title":"Epstein-Barr virus and cytomegalovirus in relation to testicular-cancer risk: a nested case-control study.","volume":"82","author":"Akre","year":"1999","journal-title":"Int J Cancer"},{"issue":"3","key":"zoi250780r23","first-page":"187","article-title":"Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies\u2013a prospective study.","volume":"4","author":"Lehtinen","year":"1993","journal-title":"Cancer Causes Control"},{"issue":"6","key":"zoi250780r24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1017\/S0022215100097255","article-title":"Long-term follow-up of IgG and IgA antibodies against viral capsid antigens of Epstein-Barr virus in nasopharyngeal carcinoma.","volume":"99","author":"Lynn","year":"1985","journal-title":"J Laryngol Otol"},{"issue":"12","key":"zoi250780r25","first-page":"1397","article-title":"Epstein-Barr virus and Burkitt lymphoma.","volume":"60","author":"Brady","year":"2007","journal-title":"J Clin Pathol"},{"issue":"6","key":"zoi250780r26","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41564-024-01699-6","article-title":"Multiple sclerosis patient-derived spontaneous B cells have distinct EBV and host gene expression profiles in active disease.","volume":"9","author":"Soldan","year":"2024","journal-title":"Nat Microbiol"},{"issue":"5","key":"zoi250780r27","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/jnnp.2008.161018","article-title":"Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.","volume":"80","author":"Pender","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"zoi250780r28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2021.100117","article-title":"Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus.","volume":"4","author":"Wood","year":"2021","journal-title":"J Transl Autoimmun"},{"issue":"3","key":"zoi250780r29","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/jmv.10213","article-title":"Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin\u2019s disease.","volume":"68","author":"Meij","year":"2002","journal-title":"J Med Virol"},{"issue":"2","key":"zoi250780r30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1442-200X.1989.tb01280.x","article-title":"Defective immune response to Epstein-Barr virus in patients with acute lymphocytic leukemia.","volume":"31","author":"Wakiguchi","year":"1989","journal-title":"Acta Paediatr Jpn"},{"issue":"22","key":"zoi250780r31","doi-asserted-by":"crossref","first-page":"8693","DOI":"10.1073\/pnas.85.22.8693","article-title":"Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency.","volume":"85","author":"Gratama","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"zoi250780r32","first-page":"338","article-title":"Discordance of Epstein-Barr Virus (EBV) specific humoral and cellular immunity in patients with malignant lymphomas: elevated antibody titres and lowered in vitro lymphocyte reactivity.","volume":"34","author":"Ten Napel","year":"1978","journal-title":"Clin Exp Immunol"},{"issue":"2-3","key":"zoi250780r33","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s12026-014-8496-1","article-title":"The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease.","volume":"58","author":"Hatton","year":"2014","journal-title":"Immunol Res"},{"issue":"10219","key":"zoi250780r34","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"zoi250780r35","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.0383","article-title":"Viral DNAemia and DNA virus seropositivity and mortality in pediatric sepsis.","volume":"7","author":"Cabler","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"21","key":"zoi250780r36","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1182\/blood.V118.21.2320.2320","article-title":"Characterization of packed red blood cells prepared with experimental multifunctional leukocyte and antibody-reduction filters.","volume":"118","author":"Silliman","year":"2011","journal-title":"Blood"},{"issue":"5","key":"zoi250780r37","first-page":"305","article-title":"Epstein-Barr virus infection in polytransfused patients with homozygous beta-thalassaemia.","volume":"37","author":"Papaevangelou","year":"1979","journal-title":"Vox Sang"},{"issue":"12","key":"zoi250780r38","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/PCC.0000000000002105","article-title":"A multicenter network assessment of three inflammation phenotypes in pediatric sepsis-induced multiple organ failure.","volume":"20","author":"Carcillo","year":"2019","journal-title":"Pediatr Crit Care Med"},{"issue":"13","key":"zoi250780r39","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome.","volume":"131","author":"Weiss","year":"2018","journal-title":"Blood"},{"key":"zoi250780r40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.698808","article-title":"Herpes DNAemia and TTV viraemia in intensive care unit critically ill patients: a single-centre prospective longitudinal study.","volume":"12","author":"Mallet","year":"2021","journal-title":"Front Immunol"},{"issue":"7","key":"zoi250780r41","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/bioinformatics\/bty769","article-title":"Mixed graphical models for integrative causal analysis with application to chronic lung disease diagnosis and prognosis.","volume":"35","author":"Sedgewick","year":"2019","journal-title":"Bioinformatics"},{"issue":"3","key":"zoi250780r42","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/bioinformatics\/bty637","article-title":"Random walk with restart on multiplex and heterogeneous biological networks.","volume":"35","author":"Valdeolivas","year":"2019","journal-title":"Bioinformatics"},{"issue":"17","key":"zoi250780r43","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1093\/bioinformatics\/btac446","article-title":"Biological Random Walks: multi-omics integration for disease gene prioritization.","volume":"38","author":"Gentili","year":"2022","journal-title":"Bioinformatics"},{"issue":"8","key":"zoi250780r44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000889","article-title":"Use of data-biased random walks on graphs for the retrieval of context-specific networks from genomic data.","volume":"6","author":"Komurov","year":"2010","journal-title":"PLoS Comput Biol"},{"issue":"14","key":"zoi250780r45","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1093\/bioinformatics\/btl234","article-title":"An integrative approach for causal gene identification and gene regulatory pathway inference.","volume":"22","author":"Tu","year":"2006","journal-title":"Bioinformatics"},{"key":"zoi250780r46","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclphysb.2019.114696","article-title":"Field theories for loop-erased random walks.","author":"Wiese","year":"2019","journal-title":"Nucl Phys B"},{"issue":"11","key":"zoi250780r47","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"zoi250780r48","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.psych.58.110405.085542","article-title":"Mediation analysis.","volume":"58","author":"MacKinnon","year":"2007","journal-title":"Annu Rev Psychol"},{"issue":"2","key":"zoi250780r49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v048.i02","article-title":"lavaan: an R package for structural equation modeling.","volume":"48","author":"Rosseel","year":"2012","journal-title":"J Stat Softw"},{"issue":"3","key":"zoi250780r50","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/path.4201","article-title":"Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.","volume":"230","author":"Lo","year":"2013","journal-title":"J Pathol"},{"issue":"7","key":"zoi250780r51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006503","article-title":"LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma.","volume":"13","author":"Cai","year":"2017","journal-title":"PLoS Pathog"},{"key":"zoi250780r52","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3389\/fmicb.2018.01233","article-title":"Epstein-Barr virus\u2013induced metabolic rearrangements in human B-cell lymphomas.","volume":"9","author":"Piccaluga","year":"2018","journal-title":"Front Microbiol"},{"issue":"4","key":"zoi250780r53","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/08916930802024772","article-title":"Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.","volume":"41","author":"Niller","year":"2008","journal-title":"Autoimmunity"},{"key":"zoi250780r54","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/978-1-4419-8216-2_7","article-title":"Epigenetic dysregulation of Epstein-Barr virus latency and development of autoimmune disease.","volume":"711","author":"Niller","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"zoi250780r55","doi-asserted-by":"crossref","DOI":"10.1177\/0961203317753069","article-title":"Epstein-Barr virus infection and type I interferon signature in patients with systemic lupus erythematosus.","author":"Han","year":"2018","journal-title":"Lupus"},{"key":"zoi250780r56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577935","article-title":"MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis.","volume":"371","author":"Aloisi","year":"2022","journal-title":"J Neuroimmunol"},{"key":"zoi250780r57","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2147\/DMSO.S370017","article-title":"Influence of hyperglycemia on the prognosis of patients with diffuse large B-cell lymphoma.","volume":"15","author":"Zhou","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"zoi250780r58","doi-asserted-by":"crossref","first-page":"514","DOI":"10.4081\/oncol.2021.514","article-title":"Metformin: its anti-cancer effects in hematologic malignancies.","volume":"15","author":"Podhorecka","year":"2021","journal-title":"Oncol Rev"},{"issue":"9","key":"zoi250780r59","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2217\/imt-2019-0002","article-title":"Immunometabolism: an overview and therapeutic prospects in autoimmune diseases.","volume":"11","author":"Stathopoulou","year":"2019","journal-title":"Immunotherapy"},{"issue":"11","key":"zoi250780r60","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1111\/jcmm.17342","article-title":"Sodium butyrate reverses lipopolysaccharide-induced mitochondrial dysfunction in lymphoblasts.","volume":"26","author":"Weiss","year":"2022","journal-title":"J Cell Mol Med"},{"issue":"2","key":"zoi250780r61","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/1573397114666180717145745","article-title":"Metformin one in a million efficient medicines for rheumatoid arthritis complications: inflammation, osteoblastogenesis, cardiovascular disease, malignancies.","volume":"15","author":"Rajaei","year":"2019","journal-title":"Curr Rheumatol Rev"},{"issue":"10","key":"zoi250780r62","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1473-3099(23)00299-2","article-title":"Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial.","volume":"23","author":"Bramante","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"zoi250780r63","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jnnp-2020-324286","article-title":"Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis.","volume":"92","author":"Cunniffe","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"zoi250780r64","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1096\/fj.201901900R","article-title":"Activation of AMP-activated protein kinase during sepsis\/inflammation improves survival by preserving cellular metabolic fitness.","volume":"34","author":"Jin","year":"2020","journal-title":"FASEB J"},{"issue":"6","key":"zoi250780r65","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/CCM.0000000000005468","article-title":"Association of metformin use during hospitalization and mortality in critically ill adults with type 2 diabetes mellitus and sepsis.","volume":"50","author":"G\u00f3mez","year":"2022","journal-title":"Crit Care Med"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2837768\/sriram_2025_oi_250780_1754932058.65952.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:00:32Z","timestamp":1755615632000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2837768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.27487","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]}}}